Prof. Qingju Zhang is a distinguished researcher at Jiangxi Normal University, China, recognized for her significant contributions to synthetic carbohydrate chemistry, glycoscience, and vaccine-related glycoconjugate development. With a portfolio of 44 peer-reviewed publications and over 870 citations across 632 citing documents, she has established a strong scholarly footprint marked by methodological innovation, collaborative strength, and impactful research outputs. Her work focuses on the chemical synthesis, structural modification, and functional exploration of complex oligosaccharides, especially those relevant to pathogenic bacteria such as Acinetobacter baumannii and Bordetella hinzii. Recent publications highlight her leadership in advancing direct glycosylation methods, visible-light-mediated stereoselective transformations, and halogen/hydrogen-bond-assisted activation strategies, reflecting her expertise in contemporary reaction design and mechanistic insight. Her research on carbohydrate-based vaccines exemplifies a translational vision aimed at developing effective immunogens targeting antibiotic-resistant bacterial pathogens. With an h-index of 16 and a network of over 110 international and interdisciplinary co-authors, she collaborates widely across chemistry, microbiology, and biomedical science communities, underscoring her role as a key contributor to global glycoscience research. In addition to pioneering synthetic methodologies, her work advances fundamental understanding of bacterial O-antigen structures and supports the design of next-generation vaccine candidates with potential societal benefits in infectious disease control. Through consistent scholarly productivity, rigorous experimental approaches, and high-impact publications in leading journals such as ACS Catalysis, Organic Letters, and JACS Au, Prof. Zhang continues to enrich the field of carbohydrate chemistry while fostering scientific collaborations that bridge basic research and biomedical application.